Canadian cannabis company Aphria Inc. told investors this week that in its most recent quarter, sales had grown 65%.

The company also reported that pull-backs from wholesale buyers across Canada due to COVID-19 has forced it to pull guidance for the full year.

CFO Carl Merton pulled the company’s full-year guidance of C$575 million ($413.5 million) to C$625 million, telling investors in a conference call early Wednesday that executive were unable to “accurately forecast the company’s year-end results” due to the coronavirus pandemic.

The company’s fiscal year ends in May and the company had already slashed its guidance when it reported second-quarter earnings.

The CFO additionally said that the company has halted new significant capital expenditures and slashed its marketing budget by C$4 million in the fourth quarter.

According to Merton, Aphria has sufficient funds for the next 12 months, a cash balance of C$515 million and no debt maturities for the next year.

Chief Executive Irwin Simon said Aphria had made several changes due to COVID-19, including staggering work schedules, increasing sanitation measures and re-designing work facilities to ensure social distancing.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Petition to Legalize Recreational Marijuana in Oklahoma Has Been Withdrawn
28 December 2019
Cronos Group Shares Are Popping This Week
18 October 2019
Michigan to Allow Big-Time Growers into The State
30 September 2017